Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Naratuximab emtansine [1] is a humanized monoclonal antibody (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) that specifically targets CD37 (TSPAN26) and serves as the basis for creating an antibody-drug conjugate (ADC) compound.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Naratuximab emtansine [1] is a humanized monoclonal antibody (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) that specifically targets CD37 (TSPAN26) and serves as the basis for creating an antibody-drug conjugate (ADC) compound. |
In vitro | Naratuximab emtansine (IMGN529), an antibody-drug conjugate (ADC), comprises a humanized anti-CD37 antibody linked to the cytotoxic agent DM1 via the same linker used in Kadcyla. |
Synonyms | Anti-TSPAN26/CD37 Reference Antibody (naratuximab) |
Molecular Weight | N/A |
CAS No. | 1622327-39-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Naratuximab 1622327-39-2 Anti-TSPAN26/CD37 Reference Antibody (naratuximab) inhibitor inhibit